Sangamo BioSciences (SGMO) Bozor kapitallashuvining balans qiymatiga nisbati
Sangamo Therapeutics (SGMO) noyob gen modifikatsiyasi tizimiga ega bo'lib, ishlab chiqarish sikllarining bir qismini va dastlabki sinovlarni tashqi pudratchilarga topshiradi. Rahbariyat hozirda moliyalashtirish yetishmovchiligi fonida o'z strategiyasini qayta ko'rib chiqmoqda va o'zining xususiy ishlanmalarini monetizatsiya qilishga intilmoqda. -4.56 darajasidagi ushbu kunlik narxlar grafigi, daromadi noyob patologiyalarni davolash sohasidagi sanoat gigantlari bilan hamkorlikka asoslangan aktivning narxlar dinamikasini aks ettiradi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SGMO_-_Sangamo-Therapeutics_-_Capitalization-to-Book-Value-Ratio "SGMO: sangamo.com Bozor qiymatining balans qiymatiga nisbati 04.07.2022 - 09.05.2026 | 👁️GURU.Markets👁️")
Sangamo Therapeutics Inc. (SGMO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Sangamo Therapeutics|SGMO - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Sangamo|SGMO - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Sangamo|SGMO - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzlari Sangamo Therapeutics|Tezkor likvidlik koeffitsiyenti sangamo.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning dastlabki tahlili:Sangamo Therapeutics
Investorlar ushbu koeffitsiyentdan kompaniyaning bozor qiymatini uning kapitaliga nisbatan baholash orqali aktivlarning haddan tashqari qimmat baholanganligini aniqlash uchun foydalanadilar. Bozor kapitalizatsiyasi va balans qiymati o'rtasidagi tarixiy bog'liqlikni tahlil qilish chakana savdo daromadlarining yo'qligi va klinik sinovlar muddatlariga qo'yilgan qat'iy FDA tartibga soluvchi cheklovlari sharoitida Sangamo Therapeutics (SGMO) baholanishi uning intellektual mulki qiymatiga qanchalik bog'liqligini ko'rsatadi.
Muhim raqobatchilar
Tempus Labs (TEM) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti qiagen.com (QGEN)|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Sarepta Therapeutics SRPT|TWST: Bozor kapitallashuvining balans qiymatiga nisbati|10x (TXG) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics|Kapitallashuvning balans qiymatiga nisbati STOK (stoketherapeutics.com)|Bozor kapitallashuvining balans qiymatiga nisbati BLFS|Wave Life Sciences Ltd (WVE) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Bozor kapitallashuvining balans qiymatiga nisbati Sionna Corp SION|PRME - Bozor qiymatining balans qiymatiga nisbati|tayshagtx.com (TSHA) - Kapitallashuvning sof aktivlarga nisbati|uniQure (QURE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti MeiraGTx Holdings (MGTX)|Kapitallashuvning sof aktivlarga nisbati RGNX|SLDB: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati OCGN (Ocugen, Inc.)|Bozor kapitallashuvining balans qiymatiga multiplikatori PACB|Bozor kapitallashuvining balans qiymatiga nisbati BNTC (Benitec Biopharma)|Balans qiymatiga nisbatan bozor qiymati DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti 4D Molecular Corp|lexeotx.com (LXEO) - Bozor qiymatining balans qiymatiga nisbati|Korro Bio - Balans qiymatiga nisbatan bozor qiymati|EDIT (Editas Medicine) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Silence Therapeutics PLC|Bozor qiymatining balans qiymatiga nisbati ProQR Therapeutics N.V. (PRQR)|CDXS: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NAUT (Nautilus Bio)|metagenomi.co (MGX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|DTIL: Kapitallashuvning sof aktivlarga nisbati|GBIO - Bozor kapitallashuvining balans qiymatiga nisbati|BOLD (Boundless Bio, Inc) - Kapitallashuvning sof aktivlarga nisbati|XCUR: Bozor kapitallashuvining balans qiymatiga multiplikatori|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|RXi Pharmaceuticals (PHIO) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MBIO|Kapitallashuvning sof aktivlarga nisbati transcodetherapeutics.com RNAZ|Bozor qiymatining balans qiymatiga nisbati Bionano Genomics BNGO|Balans qiymatiga nisbatan bozor kapitallashuvi Applied DNA Corp (APDN)|BLUE - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ImmunoPrecise Antibodies IPA|OMGA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Singular Genomics Systems, Inc. OMIC|Bozor qiymatining balans qiymatiga nisbati Regulus Therapeutics Inc|Kapitallashuvning sof aktivlarga nisbati Syros Pharmaceuticals, Inc (SYRS)|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. (TBIO)|TCON - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)